Published in Scand J Immunol on June 01, 1993
Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol (1998) 1.05
Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol (1995) 0.97
Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens. Postgrad Med J (2001) 0.95
Vaccination against meningococcus in complement-deficient individuals. Clin Exp Immunol (1998) 0.86
Phagocytic killing and antibody response during the first year after tetravalent meningococcal vaccine in complement-deficient and in normal individuals. J Clin Immunol (2000) 0.78
A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet (1999) 3.12
Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ (1997) 2.70
Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation. J Immunol (1973) 2.66
Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology (Oxford) (2007) 1.89
New, simple flow cytometry technique to discriminate between internalized and membrane-bound particles in phagocytosis. Cytometry (1989) 1.55
Isotypic analysis of antibody response to a food antigen in inflammatory bowel disease. Int Arch Allergy Appl Immunol (1985) 1.52
Predicting persistence of wheezing: one algorithm does not fit all. Eur Respir J (2010) 1.47
[Evaluation of the tinnitus retraining therapy as combined with a cognitive behavioral group therapy]. HNO (2002) 1.46
Probiotics against allergy: data, doubts, and perspectives. Allergy (2002) 1.40
Review of retrospective dosimetry techniques for external ionising radiation exposures. Radiat Prot Dosimetry (2010) 1.39
Functionally active complement proteins C6 and C7 detected in C6- and C7-deficient individuals. Clin Exp Immunol (1991) 1.22
Multiparametric flow cytometric analysis of the kinetics of surface molecule expression after polyclonal activation of human peripheral blood T lymphocytes. Scand J Immunol (1992) 1.22
Surface markers on lymphocytes of patients with infectious diseases. Infect Immun (1973) 1.21
Studies of the C3 shunt activation in cobra venom induced lysis of unsensitized erythrocytes. Proc Soc Exp Biol Med (1972) 1.19
Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study. Am J Respir Crit Care Med (1998) 1.16
Processing of tetanus toxin by human antigen-presenting cells. Evidence for donor and epitope-specific processing pathways. J Immunol (1989) 1.14
The changing epidemiology of hepatitis A in Italy. Ital J Gastroenterol (1994) 1.09
Ileal volvulus on internal hernia following left laparoscopic-assisted hemicolectomy. Surg Laparosc Endosc (1998) 1.09
Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine (2006) 1.05
Molecular basis for factor H and FHL-1 deficiency in an Italian family. Immunogenetics (2000) 1.05
Surface markers on human lymphocytes: studies of normal subjects and of patients with primary immunodeficiencies. Clin Exp Immunol (1973) 1.05
Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema. Am J Hum Genet (1996) 1.04
Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement. Pediatr Allergy Immunol (2012) 1.00
Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination. Vaccine (1993) 1.00
Infections preventing atopy: facts and new questions. Allergy (1997) 0.98
Complement activation is associated with the presence of specific human immunodeficiency virus (HIV)-anti-HIV immune complexes in patients with acquired immunodeficiency syndrome-related complex or lymphoadenopathy syndrome. Scand J Immunol (1989) 0.98
In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique. Gut (1981) 0.97
Direct and cell-mediated effects of interferon-alpha and -gamma on cells chronically infected with HTLV-III. J Interferon Res (1986) 0.97
Testing children for allergies: why, how, who and when: an updated statement of the European Academy of Allergy and Clinical Immunology (EAACI) Section on Pediatrics and the EAACI-Clemens von Pirquet Foundation. Pediatr Allergy Immunol (2013) 0.95
Spectrotype of anti-gp120 antibodies remains stable during the course of HIV disease. J Acquir Immune Defic Syndr (1992) 0.95
Atopy, hygiene, and anthroposophic lifestyle. San Marino Study Group. Lancet (1999) 0.94
The use of Phadiatop in mass-screening programmes of inhalant allergies: advantages and limitations. Clin Exp Allergy (1990) 0.94
Interferon production in primary immunodeficiencies. J Clin Immunol (1984) 0.94
The inverse association of salmonellosis in infancy with allergic rhinoconjunctivitis and asthma at school-age: a longitudinal study. Allergy (2005) 0.92
Changing epidemiology of hepatitis B in Italy: public health implications. Am J Epidemiol (1992) 0.92
Prospective validation of 'Allergy-Control-SCORE(TM)': a novel symptom-medication score for clinical trials. Allergy (2011) 0.91
Detection and partial characterization of circulating immune complexes in hydatid disease. J Clin Microbiol (1983) 0.91
Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. J Clin Immunol (1990) 0.91
Primary prevention of allergy: avoiding risk or providing protection? Clin Exp Allergy (2007) 0.90
Circulating immune complexes detected by C1q solid phase assay in leprosy. Int J Lepr Other Mycobact Dis (1981) 0.90
Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines. Infect Immun (1988) 0.89
Serum and salivary IgA levels in normal subjects: comparison between tonsillectomized and non-tonsillectomized subjects. Int Arch Allergy Appl Immunol (1982) 0.89
Raised serum levels of IgM-rheumatoid factor and anti-F(ab')2 autoantibodies in patients with active inflammatory bowel disease. J Clin Lab Immunol (1986) 0.88
Presentation of superantigen by human T cell clones: a model of T-T cell interaction. Eur J Immunol (1992) 0.87
Staphylococcus aureus enterotoxin-specific IgE is associated with asthma in the general population: a GA(2)LEN study. Allergy (2013) 0.87
Reference typing report for complement receptor 1 (CR1). Exp Clin Immunogenet (1998) 0.87
Evaluation of the overall degree of sensitization to airborne allergens by a single serologic test: implications for epidemiologic studies of allergy. J Allergy Clin Immunol (1994) 0.85
Defective interferon-gamma production in ataxia-telangiectasia. Clin Immunol Immunopathol (1984) 0.85
Circulating immune complexes in normal pregnant women and in some conditions complicating pregnancy. Clin Exp Immunol (1979) 0.85
Alternate complement pathway: elevation of cobra venom-induced hemolytic activity in sera of tumor-bearing mice. J Immunol (1973) 0.85
Prostaglandin production by human polymorphnuclear leucocytes during phagocytosis in vitro. Experientia (1977) 0.85
Rapidly progressive periodontitis. Neutrophil chemotaxis inhibitory factors associated with the presence of Bacteroides gingivalis in crevicular fluid. J Periodontol (1987) 0.84
Conservative laparoscopy in the treatment of posttraumatic splenic laceration using microfiber hemostatic collagen: three case histories. Surg Laparosc Endosc (1998) 0.84
Clinical and immunological response to typhoid vaccination with parenteral or oral vaccines in two groups of 30 recruits. Vaccine (1993) 0.84
Flow cytometric evaluation of nitro blue tetrazolium (NBT) reduction in human polymorphonuclear leukocytes. Cytometry (1990) 0.84
Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy. Scand J Immunol (1992) 0.84
Antigen-specific detection of soluble immune complexes in conglutinin-binding assays. Clin Exp Immunol (1981) 0.84
Risk management of HBsAg or anti-HCV positive healthcare workers in hospital. Dig Liver Dis (2001) 0.84
Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles. J Immunol (1994) 0.84
Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents. Clin Exp Immunol (2014) 0.83
Allergy, asthma and markers of infections among Albanian migrants to Southern Italy. Allergy (2004) 0.83
Defective neutrophil chemotaxis in hypogammaglobulinemia and selective IgA deficiency. Clin Immunol Immunopathol (1980) 0.83
Quantitative and qualitative analysis of anti-tetanus toxoid antibody response in the elderly. Humoral immune response enhancement by thymostimulin. Vaccine (1993) 0.83
Predicting the outcome of oral food challenges with hen's egg through skin test end-point titration. Clin Exp Allergy (2009) 0.83
Neutrophil chemotaxis defect in IgA deficiency evaluated by migration agarose method. Scand J Immunol (1980) 0.83
The effects of hypobaric hypoxia on specific B cell responses following immunization in mice and humans. Aviat Space Environ Med (1991) 0.82
Comparison of pathologic and normal sera by immune complex determination: five disease groups within 190 samples are discriminated by computer-selected combinations of 13 methods. Report of the Italian committee for the study of immune complexes (WIC). Clin Immunol Immunopathol (1984) 0.82
Tetracycline inhibits the nitric oxide synthase activity induced by endotoxin in cultured murine macrophages. Eur J Pharmacol (1998) 0.82
Cobra venom-induced hemolysis. Activity levels in sera of patients with neoplastic and other diseases. J Exp Med (1972) 0.81
Can the military contribute to global surveillance and control of infectious diseases? Emerg Infect Dis (1999) 0.81
Humoral inhibition of neutrophil chemotaxis in Crohn's disease. Scand J Immunol (1985) 0.81
Clonotypic analysis of human antibodies specific for Neisseria meningitidis polysaccharides A and C in adults. Clin Exp Immunol (1991) 0.81
Immunologic and clinical investigation on a bovine thymic extract. Therapeutic applications in primary immunoedificiencies. Pediatr Res (1979) 0.81
Prevalence of markers of exposure to Bordetella pertussis among Italian young adults. Clin Infect Dis (1998) 0.81
Modification of peripheral blood T-lymphocyte surface receptors and Langerhans cell numbers in hereditary angioedema. Am J Clin Pathol (1986) 0.81
Characterization of specific immune complexes in HIV-related disorders. Scand J Immunol (1987) 0.80
Thalassemia major terminating in a non-Hodgkin B-cell lymphoma: report of a case. Tumori (1979) 0.80
Changes in thymocyte subsets induced by estradiol administration or pregnancy. Ann N Y Acad Sci (1992) 0.80
Complement activation by cell-associated immune complexes in contact sensitivity. Cell Immunol (1984) 0.80
Imaging B lymphocytes in autoimmune inflammatory diseases. Q J Nucl Med Mol Imaging (2014) 0.80
Circulating immune complexes in amoebiasis. Trans R Soc Trop Med Hyg (1982) 0.80
Incidence of hepatitis A virus infection among an Italian military population. Infection (1994) 0.80
Lymphoid cells in infectious mononucleosis classified according to T and B cell markers. Int Arch Allergy Appl Immunol (1975) 0.80
In vitro effect of ketoconazole on human neutrophil chemotaxis and Candida albicans killing. Boll Ist Sieroter Milan (1983) 0.79
Methodological aspects of the application of the Naka-Rushton equation to clinical electroretinogram. Ophthalmic Res (1993) 0.79
ERG signal analysis using wavelet transform. Theory Biosci (2011) 0.79
Intravenous immunoglobulin preparations: a comparative in vitro study of Fc mediated functions. J Clin Lab Immunol (1989) 0.79
The heterogeneity of allergic phenotypes: genetic and environmental interactions. Ann Allergy Asthma Immunol (2001) 0.79
One cause for the apparent inability of human T cell clones to function as professional superantigen-presenting cells is autoactivation. Eur J Immunol (1996) 0.79
A case of subacute cutaneous lupus erythematosus in a patient with mixed connective tissue disease: successful treatment with plasmapheresis and rituximab. Case Rep Rheumatol (2013) 0.78